| Protocols | ||
|---|---|---|
| 2 protocol(s) meet the specified criteria | ||
| PI: Vandeventer, Hendrik | ||
| Protocol No. | Title | Status |
| CALGB10404 | A Genetic, Risk-Stratified Randomized Phase II Study of Four Fludarabine/Antibody Combinations for Patients with Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia | Open (affiliates only) |
| CALGB50403 | A Randomized Phase II Trial of Maintenance vs Consolidation Bortezomib Therapy Following Aggresive Chemo-Immunotherapy and Autologous Stem Cell Transplant for Previously Untreated Mantle Cell Lymphoma | Open (affiliates only) |